Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin PK and Safety in Pediatric Neurogenic Bladder
NCT00629720Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of alfuzosin in neurogenic bladder, sponsored by Sanofi. Started Jul 2006; status: completed.
02
Drugs
alfuzosin
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on NCT00629720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629720.